Troy E. Wilson
2019
In 2019, Troy E. Wilson earned a total compensation of $3.2M as President and Chief Executive Officer at Kura Oncology, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $290,275 |
|---|---|
| Option Awards | $2,327,952 |
| Salary | $542,000 |
| Other | $75,990 |
| Total | $3,236,217 |
Wilson received $2.3M in option awards, accounting for 72% of the total pay in 2019.
Wilson also received $290.3K in non-equity incentive plan, $542K in salary and $76K in other compensation.
Rankings
In 2019, Troy E. Wilson's compensation ranked 3,767th out of 13,971 executives tracked by ExecPay. In other words, Wilson earned more than 73.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,767 out of 13,971 | 73rd |
Division Manufacturing | 1,363 out of 5,695 | 76th |
Major group Chemicals And Allied Products | 475 out of 2,194 | 78th |
Industry group Drugs | 399 out of 1,880 | 79th |
Industry Pharmaceutical Preparations | 301 out of 1,392 | 78th |
Source: SEC filing on April 28, 2020.
Wilson's colleagues
We found five more compensation records of executives who worked with Troy E. Wilson at Kura Oncology in 2019.